Skip to main content
Clinical Trials/TCTR20240409004
TCTR20240409004
Not yet recruiting
Not Applicable

The Venous Excess Ultrasound (VExUS) grading to predict tolerance to fluid de-escalation in critically ill patients

Faculty of Medicine Ramathibodi Hospital, Mahidol University0 sites65 target enrollmentApril 9, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Critically ill patientsCirculatory shockFluid de-escalation
Sponsor
Faculty of Medicine Ramathibodi Hospital, Mahidol University
Enrollment
65
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 9, 2024
End Date
March 31, 2025
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\.Adult patients (age 18 years and over) admitted in intensive care units (both medical and surgical ICU) of Ramathibodi Hospital
  • 2\.Presence of fluid accumulation, defined as positive fluid balance 10% or more of body weight
  • 3\.Hemodynamic stability, defined as
  • a. Adequate tissue perfusion (capillary refilling time less than 3 seconds)
  • b. Mean arterial pressure more than 65 mmHg with
  • i.Clearing decreasing dose of vasopressor
  • ii.Norepinephrine less than 0\.2 mcg/kg/min
  • iii.Arterial lactate level less than 2 mmol/L
  • 4\.Need for fluid de\-escalation, as decided by the attending physicians

Exclusion Criteria

  • 1\.Patients who refused to participate in the study or withdraw from the study
  • 2\.Patients who had severe chronic kidney disease (estimated glomerular filtration rate less than 15 mL/min per 1\.73 m2 or in regular dialysis program) or renal transplantation
  • 3\.Patients with obstacles to abdominal ultrasound include severe obesity (BMI of 40 or higher), having had abdominal surgery or having abdominal burn wounds in the positions that may impede ultrasound.
  • 4\.Patients with previously known conditions that interfere with portal Doppler assessments (liver cirrhosis, portal vein thrombosis, or severe tricuspid regurgitation with structural heart disease)
  • 5\.Pregnancy

Outcomes

Primary Outcomes

Not specified

Similar Trials